Virtus Investment Partners

VRTS · NYSE

$120.08+$2.34 (+1.99%)TodayMarket closed · Oct 20, 7:35 PM ET

Prev close $117.74

VRTS analyst rating

HoldConsensus of 4 analysts over the last 12 months. 25% rate it a buy.

Strong buy0
Buy1
Hold1
Underperform2
Sell0

12-month price target · 6 analysts

Average $149.94 (+24.9% upside)

Low: $121.20
Now: $120.08
High: $180.60

Upgrades and downgrades

The latest rating actions, newest first

VRTS analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Piper Sandler	Oct 19, 2026	Maintains	Overweight	$172.00 → $146.00	37%
Barclays	Oct 14, 2026	Maintains	Underweight	$135.00 → $117.00	57%
TD Cowen	Oct 12, 2026	Maintains	Hold	$155.00 → $136.00	53%
Morgan Stanley	Sep 25, 2026	Maintains	Underweight	$130.00 → $120.00	54%
Barclays	Jul 31, 2026	Maintains	Underweight	$141.00 → $135.00	57%
TD Cowen	Jul 20, 2026	Maintains	Hold	$136.00 → $147.00	53%
Barclays	Jul 14, 2026	Maintains	Underweight	$125.00 → $141.00	57%
Morgan Stanley	Jun 26, 2026	Maintains	Underweight	$112.00 → $119.00	54%
Morgan Stanley	May 19, 2026	Maintains	Underweight	$128.00 → $112.00	54%
TD Cowen	May 4, 2026	Maintains	Hold	$132.00 → $131.00	53%

The case for and against

Updated Oct 7, 2025

Bull case

Virtus Investment Partners Inc. is poised for a positive outlook due to projected improvements in its net outflows and organic losses. The company anticipates net outflows of $2.8 billion in the first quarter of 2025, which reflects a reduction from the previous quarter's performance, supported by inflows from ETFs and an uptick in institutional investment. Additionally, the annualized organic losses are expected to decrease to -6.5% from -10.5%, indicating a potential stabilization and recovery in the company's financial health.

Bear case

Virtus Investment Partners Inc. faces a challenging outlook due to a year-to-date decline of approximately 10% in the S&P 500, which has exerted downward pressure on its financial estimates. The company's adjusted EPS estimate for 1Q25 has been revised downwards to $5.59 from a previous estimate of $5.62, and 2025/2026 earnings projections have also been reduced by approximately 2%. Additionally, preliminary average assets under management (AUM) for 1Q25 have decreased to $174 billion, representing a 4.7% decline quarter-over-quarter, further indicating a deterioration in the company's financial health.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.